General Biologicals Corporation (4117.TWO) Stock
—
Valuation
Financials & Margins
Valuation & Return Ratios
Ownership
About General Biologicals Corporation
—
General Biologicals Corporation is led by CEO Frank Lin, employs 200 people, headquartered in Hsinchu City, TW, publicly traded since 2007.
General Biologicals Corporation (4117.TWO) stock trades at $7.30 with a market capitalization of $598.19M. The stock is valued at a price-to-earnings (P/E) ratio of 1.00, price-to-book of 0.75, price-to-sales of 2.30. Over the past 52 weeks the stock has ranged between $3.50 and $17.30, and currently trades 57.8% below its 52-week high.
On profitability, General Biologicals Corporation generates a return on equity (ROE) of 108.50%, above the typical market range of roughly 12-15%, an operating margin of -27.78%, a net profit margin of 199.43%.
Official website: www.gbc.com.tw
General Biologicals Corporation (4117.TWO) — frequently asked questions
What is General Biologicals Corporation (4117.TWO) stock price today?
General Biologicals Corporation (4117.TWO) is currently trading at $7.30, down 16.48% today.
What is 4117.TWO P/E ratio?
General Biologicals Corporation's P/E ratio is 1.00. This is below the typical market average of roughly 18-22x. A low P/E can reflect a lower valuation, slower expected growth, or both.
What is 4117.TWO return on equity (ROE)?
General Biologicals Corporation's return on equity (ROE) is 108.50%. ROE measures net income relative to shareholders' equity. This is above the typical market range of roughly 12-15%.
What is General Biologicals Corporation's market cap?
General Biologicals Corporation has a market capitalization of $598.19M.
Does 4117.TWO pay a dividend?
General Biologicals Corporation is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 4117.TWO carry?
General Biologicals Corporation has a debt-to-equity ratio of 3.17. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 4117.TWO's profit margin?
General Biologicals Corporation reports a net profit margin of 199.43% — the share of revenue left after every cost, including tax and interest.
What sector is 4117.TWO in?
General Biologicals Corporation is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 4117.TWO listed on?
General Biologicals Corporation trades on TWO under the ticker 4117.TWO.
What is 4117.TWO's 52-week range?
Over the last year General Biologicals Corporation has traded between $3.50 and $17.30.
Related — Stocks
Popular Stocks
Screens 4117.TWO currently matches
On the figures above, General Biologicals Corporation passes the filters for 21 of our ready-made screens, among them Low PE Stocks, Low PB Stocks, Day Losers Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.